4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Nanotechnology and Cardiovascular Medicine
The use of nanoparticles is revolutionizing the way we approach heart disease, offering more targeted and effective treatments. Nanotechnology and cardiovascular medicine are becoming increasingly intertwined, providing innovative solutions for drug delivery systems that directly target affected areas of the heart. By minimizing side effects and increasing the efficacy of treatments, these advances hold significant promise. Additionally, nanotechnology is improving diagnostic capabilities, allowing for earlier detection of cardiovascular conditions with greater accuracy. As research in nanomedicine continues to progress, it opens up exciting possibilities for tissue regeneration and the development of artificial blood vessels, offering hope for those with chronic cardiovascular issues.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, Bahrain
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Characterizing cardiac ECG and echocardiographic abnormalities in cirrhotic patients with and without heart failure
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States